These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy. Micheletti E; Riva I; Bruttini C; Quaranta L J Glaucoma; 2020 Aug; 29(8):e87-e90. PubMed ID: 32568812 [TBL] [Abstract][Full Text] [Related]
5. Device-modified trabeculectomy for glaucoma. Park J; Rittiphairoj T; Wang X; E JY; Bicket AK Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740 [TBL] [Abstract][Full Text] [Related]
6. Retrospective Analysis of 12 Months Glaucoma Implant Efficacy: XEN45 and PreserFlo Microshunt. Saletta G; Alexoudis A; Gatzioufas Z; Grieshaber M; Papazoglou A; Tschopp M; Töteberg M; Gugleta K Klin Monbl Augenheilkd; 2022 Apr; 239(4):429-434. PubMed ID: 35472784 [TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom. Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904 [TBL] [Abstract][Full Text] [Related]
9. Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: A registry study. Bøhler AD; Traustadóttir VD; Hagem AM; Tønset TS; Drolsum L; Kristianslund O Acta Ophthalmol; 2024 Mar; 102(2):186-191. PubMed ID: 37340695 [TBL] [Abstract][Full Text] [Related]
10. PreserFlo MicroShunt® exposure: a case series. Bunod R; Robin M; Buffault J; Keilani C; Labbé A; Baudouin C BMC Ophthalmol; 2021 Jul; 21(1):273. PubMed ID: 34246229 [TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772 [TBL] [Abstract][Full Text] [Related]
12. Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study. Batlle JF; Corona A; Albuquerque R J Glaucoma; 2021 Mar; 30(3):281-286. PubMed ID: 33137019 [TBL] [Abstract][Full Text] [Related]
13. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. Saeed E; Gołaszewska K; Dmuchowska DA; Zalewska R; Konopińska J Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833599 [TBL] [Abstract][Full Text] [Related]
14. Single versus Double PreserFlo MicroShunt Implantation in Glaucoma Patients: A Retrospective Cohort Study. Dervos T; Gugleta K; Scholl HPN; Gatzioufas Z; Enz TJ Ophthalmic Res; 2023; 66(1):1362-1375. PubMed ID: 37972571 [TBL] [Abstract][Full Text] [Related]
15. A simple surgical solution for the treatment of persistent postoperative hypotony after PRESERFLO MicroShunt implantation. Aguilar-Munoa S; Tham YH; Barton K Eye (Lond); 2023 Jul; 37(10):2126-2129. PubMed ID: 36434286 [TBL] [Abstract][Full Text] [Related]
16. The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony. Verma-Fuehring R; Dakroub M; Bamousa A; Kann G; Hillenkamp J; Kampik D Graefes Arch Clin Exp Ophthalmol; 2024 Jul; ():. PubMed ID: 38969777 [TBL] [Abstract][Full Text] [Related]